Part of our series: Spring ’26 in Pharma: Through an Architect’s Lens

TL;DR — Key Takeaways

1. Prior authorization is one of the highest-volume, most documentation-heavy workflows in life sciences — and one of the best fits for AI assistance.
2. AI handles data extraction and normalization from complex intake documents. A human confirms accuracy before anything moves forward.
3. A compliance-aware prior auth workflow requires two human checkpoints — intake review and clinical decision. Neither can be removed.
4. Every AI output in a regulated prior auth workflow must be traceable back to a prompt, model version, and human decision-maker.
5. Getting prior auth right with AI is less about the technology and more about how narrowly you define what each agent is allowed to do.

Ask any intake agent what their day looks like, and prior authorization comes up fast. Not because it’s complicated in concept — it’s not. But because the volume is relentless and the documentation that comes with each request is a lot for any person to work through manually.

That’s exactly why prior authorization has become one of the first places life sciences organizations are putting AI to work. Not to make the decision. To handle everything that happens before a human can.

(For the broader picture on how human-in-the-loop AI works across regulated healthcare workflows, start with our Month 2 hub post: AI Can’t Make the Call — Here’s Why That’s Actually the Point.)

What makes prior authorization so difficult to process manually?

Prior authorization is hard to process manually because of what comes with each request — not the request itself.

A physician submits a prior auth for a patient. Attached to that request is a stack of documentation: patient demographics, insurance information, a scanned insurance card, the treating physician’s diagnosis, the patient’s medical history, treatment history, diagnostic codes, therapy codes, and often pages of office notes.

Jeff Sumption, Salesforce Solution Architect at CI Digital, has seen this firsthand across life sciences clients. He describes the intake challenge plainly:

— Jeff Sumption, Salesforce Solution Architect, CI Digital

Each of those document types arrives in a different format. Some are structured data. Some are scanned PDFs. Some are free-form clinical notes written in a physician’s shorthand. An intake agent has to read all of it, extract what’s relevant, and enter it into the system before the workflow can even begin.

Multiply that by the volume a typical hub or specialty pharmacy handles in a week, and the manual burden becomes a real bottleneck — one that directly delays a patient’s time to first treatment.

How does AI improve the prior authorization intake process?

AI improves prior authorization intake by handling the document-heavy work that slows agents down before they can do their actual job.

Using Natural Language Processing, an AI model reads the incoming documentation — regardless of format — identifies the relevant information in context, and pushes structured data directly into Salesforce. Patient demographics populate the right fields. Insurance details get matched. Diagnostic and therapy codes get extracted and recorded.

What used to take an agent 15 to 20 minutes of manual entry now happens in seconds. The agent’s job shifts from data entry to data review — which is faster, less error-prone, and still keeps a human in the loop where accuracy matters most.

That review step is not optional. It is the first human checkpoint, and it has to stay in the workflow. AI extracts. A human confirms. Then the case moves forward.

What does a compliant AI prior authorization workflow look like on Salesforce?

A compliant prior auth workflow on Salesforce uses narrow, task-specific AI agents — each with a hard-coded scope and a defined set of permitted outputs.

Jeff describes the Intake Agent as the right model for how this works in practice:

— Jeff Sumption, Salesforce Solution Architect, CI Digital

After the agent completes intake and the human reviewer confirms accuracy, the data moves to the next stage. Here, AI can play a second role — analyzing the structured data to surface potential coverage issues, flag gaps, or help the agent understand how to disposition the request. This is decision support, not decision-making.

Then comes the second human checkpoint: a medical professional reviews the full documentation and the AI’s analysis before any approval or denial goes out. That person owns the outcome. The AI informed the process. It did not run it.

This two-checkpoint structure is not just good practice — it is what the FDA and EU regulatory frameworks require. Both have been clear that AI in clinical workflows must support human decision-makers, not replace them.

Is your prior authorization workflow ready for AI? The team at CI Digital helps life sciences organizations design compliant, Salesforce-native AI workflows that reduce intake time without creating regulatory risk. Let’s talk.

What has to happen before AI touches prior authorization data?

Before any patient data reaches an AI model, it has to be scrubbed.

Prior authorization documents contain some of the most sensitive information in healthcare — names, social security numbers, medical record numbers, diagnoses, insurance IDs. All of it qualifies as protected health information under HIPAA. None of it should enter an LLM without going through a governance process first.

That means personally identifiable information gets removed before the data hits the model. Outputs get checked for bias. And every prompt, every context window, and every model output gets captured in an immutable audit trail — tied back to the model version, the data snapshot, and the human who made the final call.

This is what compliance-aware AI actually means in practice. It is not a setting you turn on. It is an architecture you design from day one.

Why does prior authorization work so well as an AI starting point?

Prior authorization works well as an AI starting point because the task is high-volume, the documents are repetitive in structure, and the human checkpoints are easy to define and enforce.

It is also low enough in clinical risk at the intake stage that a narrow AI agent can operate within a clear compliance perimeter without creating exposure. The agent does one thing. It does it consistently. A human checks the work. The case moves.

That is the pattern every life sciences organization should be building from — not broad agents with wide permissions, but specific tools with specific jobs that make the humans in the workflow faster and more accurate.

Get prior auth right, and you have a template for everything else.

Frequently Asked Questions

What is prior authorization AI automation in life sciences?

Prior authorization AI automation uses machine learning and NLP to extract data from incoming request documents, populate fields in platforms like Salesforce, and surface coverage insights — while keeping human reviewers in control of the actual approval or denial decision.

Can AI fully automate prior authorization decisions?

No. FDA and EU regulatory frameworks both require human oversight for clinical decisions. AI can automate data intake and surface recommendations, but a qualified medical professional must review the documentation and own the final disposition.

What Salesforce tools support prior authorization workflows in pharma?

Salesforce Life Sciences Cloud and Agentforce both support prior auth workflows. Narrow AI agents can be configured to handle document extraction and payer API queries within hard-coded compliance perimeters, with human review built into the workflow at every decision point.

What data governance is required before AI processes prior auth documents?

All personally identifiable information — names, SSNs, medical record numbers, insurance IDs — must be removed before data reaches an AI model. Every prompt and output must be logged in an immutable audit trail tied to a model version and human decision-maker.

Why is prior authorization a good starting point for AI in life sciences?

Prior auth intake is high-volume, document-heavy, and repetitive enough that a narrow AI agent can operate within a clear compliance perimeter. The human checkpoints are easy to define, making it one of the lowest-risk places to build confidence in AI-assisted workflows.

Up Next:

→ Next in the series: What It Actually Takes to Scale AI in Life Sciences — the gap between running a successful pilot and building something that actually holds up at scale. Coming soon.

This post is part of our Spring ’26 series. Read the full overview: Spring ’26 in Pharma — Through an Architect’s Lens.

Want to see what compliant AI workflows look like for your team? Connect with CI Digital and let’s walk through where AI fits in your current Salesforce prior authorization setup. Get in touch.